Corticosteroid therapy encompasses the use of glucocorticoids and mineralocorticoids for their potent anti-inflammatory, immunosuppressive, and hormone replacement effects. Glucocorticoids are among the most widely prescribed medications due to their efficacy across a broad range of inflammatory, autoimmune, allergic, and neoplastic conditions. Their use requires careful risk-benefit assessment due to significant adverse effects with chronic high-dose therapy.
What Is Corticosteroid Therapy?
The adrenal cortex produces cortisol (glucocorticoid) and aldosterone (mineralocorticoid), which are essential for stress response, metabolism, and electrolyte homeostasis. Pharmacological corticosteroid therapy can be physiologic (replacement of deficient endogenous hormone) or pharmacologic (supraphysiologic doses for therapeutic effect). The choice of agent, dose, route, and duration is determined by the condition being treated and patient-specific factors.
Drug Classes and Mechanisms
Glucocorticoids include hydrocortisone (equivalent to endogenous cortisol), prednisone and its active metabolite prednisolone, methylprednisolone, triamcinolone, and dexamethasone. These agents bind the glucocorticoid receptor, which translocates to the nucleus and modulates gene transcription through transrepression (inhibiting pro-inflammatory transcription factors such as NF-kB and AP-1) and transactivation (upregulating anti-inflammatory proteins such as lipocortin-1). Mineralocorticoids include fludrocortisone, which binds the mineralocorticoid receptor and promotes sodium retention and potassium excretion in the distal renal tubule, used for replacement therapy in adrenal insufficiency.
Therapeutic Uses
Prednisone and prednisolone are the most commonly used oral glucocorticoids for chronic inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and asthma. Dexamethasone is preferred for cerebral edema, COVID-19 requiring oxygen, and antenatal therapy to promote fetal lung maturation due to its minimal mineralocorticoid activity and long duration. Methylprednisolone is used for high-dose pulse therapy in severe acute inflammatory conditions. Hydrocortisone is preferred for physiologic replacement in adrenal insufficiency and stress-dose coverage during illness or surgery. Routes of administration include oral, intravenous, intramuscular, topical, inhaled, intra-articular, and ophthalmic preparations.
Adverse Effects
Chronic glucocorticoid use causes Cushing’s syndrome with central obesity, moon facies, buffalo hump, and skin thinning. Metabolic effects include hyperglycemia, diabetes mellitus, hypertension, and dyslipidemia. Musculoskeletal complications include osteoporosis, avascular necrosis, and proximal myopathy. Adrenal suppression occurs with prolonged therapy and requires gradual tapering to allow recovery of the hypothalamic-pituitary-adrenal axis. Other effects include immunosuppression, increased infection risk, cataracts, glaucoma, and psychiatric disturbances ranging from insomnia to psychosis. Mineralocorticoid excess from fludrocortisone causes hypertension, hypokalemia, and fluid retention.
Key Clinical Considerations
The lowest effective dose for the shortest duration should be used. Tapering is essential after more than 2 to 3 weeks of therapy to prevent adrenal crisis. Patients on chronic therapy require stress-dose coverage during surgery, infection, or other acute illness. Calcium and vitamin D supplementation and bisphosphonate therapy are recommended for osteoporosis prevention. Inhaled and topical corticosteroids minimize systemic absorption but carry their own local side effects.
Conclusion
Corticosteroids are potent therapeutic agents with broad applications across medicine. Their efficacy in controlling inflammation and immune-mediated disease is unmatched, but chronic use is limited by a predictable and potentially severe adverse effect profile. Judicious dosing, regular monitoring, and proactive mitigation strategies are essential to optimize outcomes and minimize harm.
